Téléversements by Morcos

Health-Canada-2012-Cleaning-Validation-(GUI-0028).pdf

qa_safetyfeature_v7_0.pdf

EMA Aut g0006 Guide to Parallel Imports Human Medicines v12

FDA Aseptic 5882fnl.pdf

FDA Biological Indicator 1320.pdf

FDA Quality Metrics Submission 1063761 RevDraft.pdf

FDA Presentation on 7.ISO14644.pdf

FDA Pre-marketing Risk Assessment 04d-0187-gdl0002.pdf

FDA cGMP Phase 1 Clinical Trials.pdf

FDA GLP Q&A.pdf

FDA NEW TECH.pdf

FDA 25591_Data Integrity.pdf

FDA OOS UCM070287.pdf

FDA Denial Inspection ORA201320 FDASIA 707 Final Guidance Sept 23 2014

FDA Changes Biopharma

FDA Changes Biopharma Annual Report

FDA CSV Clinical Trials.pdf

EMA Annex 1 update.pdf

2017_11_22_guidelines_gmp_for_atmps.pdf

MHRA-Out_of_Specification_v02_1_.pdf

MHRA_GxP_data_integrity_guide_March_edited_Final.pdf

MHRA GxP Data Integrity Definitions and Guidance

APIC_CEFIC_AuditingGuideAugust2016

FDA CSV Clinical Trials

FDA CSV Clinical Trials.pdf

FDA Aseptic 5882fnl

FDA Pre-marketing Risk Assessment 04d-0187-Gdl0002

GS1 DataMatrix Guideline

USP 1231.pdf

WHTM 01-01 Part B

Steam Sampler

HTM 2031 1997